Skip to content

Comparison of intravenous and oral dexamethasone in perioperative pain control after total knee arthroplasty

Comparison of intravenous and oral dexamethasone in perioperative pain control after total knee arthroplasty: A Prospective, Randomized Controlled, Non-inferiority Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011788
Enrollment
94
Registered
2026-03-30
Start date
2026-04-06
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This study is a prospective, randomized, non-inferiority interventional trial comparing oral dexamethasone with intravenous dexamethasone in patients undergoing total knee arthroplasty. Partici

Sponsors

Seoul Metropolitan Government Seoul National University Boramae Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with primary knee osteoarthritis who undergo total joint arthroplasty are eligible. - In cases where bilateral procedures are performed during the same hospitalization at separate time points, only the first operated knee will be included in the study.

Exclusion criteria

Exclusion criteria: A. Patients with types of arthritis other than primary osteoarthritis (e.g., rheumatoid arthritis, inflammatory arthritis, post-traumatic arthritis, neuropathic arthropathy) B. Patients currently taking neuropsychiatric medications C. Patients diagnosed with diabetes mellitus, or those with a preoperative glycated hemoglobin (HbA1c) level = 6.5% even without a prior diagnosis D. Patients receiving corticosteroids preoperatively due to underlying medical conditions E. Patients who wish to use patient-controlled analgesia (PCA) after surgery F. Patients with chronic kidney disease or a glomerular filtration rate (GFR) < 60 mL/min/1.73 m², in whom postoperative use of anti-inflammatory drugs is limited

Design outcomes

Primary

MeasureTime frame
The mean numerical rating scale(NRS) pain score during activity from the day of surgery to postoperative day 5.

Secondary

MeasureTime frame
Numerical rating scale(NRS) pain scores at rest and during activity from the day of surgery to postoperative day 5; Amount of rescue analgesics administered from the day of surgery to postoperative day 5;Severity of nausea and vomiting from the day of surgery to postoperative day 5;Adverse events;Patient-reported outcome measures (PROMs)

Countries

Korea, Republic of

Contacts

Public ContactJisu Park

Seoul Metropolitan Government Seoul National University Boramae Medical Center

pjswltn@gmail.com+82-2-870-2312

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Apr 17, 2026